Procalcitonin as an acute phase marker

Annals of Clinical Biochemistry

Volumn 38, Issue 5, 2001, Pages 483-493

  Whicher, J ^a   Bienvenu, J ^a   Monneret, G ^a  

^a Rush House   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CALCITONIN; GENE PRODUCT; KATACALCIN; PROCALCITONIN;

ACUTE PHASE RESPONSE; BACTERIAL INFECTION; HUMAN; IMMUNE COMPLEX DISEASE; MONITORING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN SYNTHESIS REGULATION; REVIEW; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TISSUE INJURY; TISSUE SPECIFICITY;

ACUTE-PHASE REACTION; BIOLOGICAL MARKERS; CALCITONIN; HUMANS; INFANT, NEWBORN; INFECTION; INTENSIVE CARE UNITS; POSTOPERATIVE COMPLICATIONS; PROTEIN PRECURSORS; SURGICAL WOUND INFECTION; TRANSPLANTATION;

BACTERIA (MICROORGANISMS);

EID: 0034853096     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/0004563011901299     Document Type: Review

References (62)

1. American College of Chest Physicians - Society of Critical Care Medicine Consensus Conference. Definitions of sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
2. Acute phase proteins - A group of protective proteins
3. The complete sequence of human preprocalcitonin
4. Structure and methylation of the human calcitonin/alpha-CGRP gene
5. A novel calcitonin-encoding mRNA is produced by alternative processing of calcitonin/calcitonin gene-related peptide-I-pre-mRNA
6. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products
7. Stimulation of noradrenergic outflow by calcitonin gene-related peptide
8. Differential effects of neuropeptides on cytokine production by mouse helper T cell subsets
9. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing
10. Procalcitonin increase after endotoxin injection in normal subjects
11. High serum procalcitonin concentrations in patients with sepsis and infection
12. Structural characterisation of a high-molecular-mass form of calcitonin {procalcitonin-(60-116)-peptide} and its corresponding N-terminal flanking peptide {procalcitonin-(1-57)-peptide} in a human medullary thyroid carcinoma
13. Biosynthesis of calcitonin gene-related peptide and calcitonin by a human medullary carcinoma cell line
14. Identification of procalcitonin in a rat medullary thyroid carcinoma cell line
15. Biosynthesis of procalcitonin in small cell carcinoma of the lung
16. Calcitonin heterogeneity in lung cancer and medullary thyroid cancer
17. Immunocytochemical localisation of calcitonin in Kulschitzky cells of human lung
18. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis related cytokines in vitro
19. Procalcitonin as monocytic marker for early diagnosis in septic abortus
20. Katacalcin and calcitonin immunoreactivity in different types of leukocytes indicate intracellular procalcitonin content
21. Procalcitonin is not produced by circulating blood cells
22. Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro
23. Induction of systemic serum procalcitonin and cardiocirculatory reactions after isolated limb perfusion with recombinant human tumour necrosis factor-α and melphalan
24. Procalcitonin modulates the proinflammatory response in vitro
25. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis
26. Molecular aspects and natural source of procalcitonin
27. Identification and measurement of calcitonin precursors in serum of patients with malignant diseases
28. Procalcitonin - Influence of temperature, storage, anticoagulation and arterial or venous asservation of blood samples on procalcitonin concentrations
29. Procalcitonin: Analytical aspects and preliminary clinical data
30. Hypercalcitoninaemia in fulminant meningococcaemia in children
31. Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome
32. Procalcitonin in early detection of postoperative complications
33. Postoperative plasma concentrations of procalcitonin after different types of surgery
34. Diagnostic value of procalcitonin: The influence of cardiopulmonary bypass, aprotinin, SIRS and sepsis
35. Hyperprocalcitoninemia in patients with noninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass
36. Detection of acute phase response and infection. The role of procalcitonin and C-reactive protein
37. Serum procalcitonin as an index of inhalation burn injury in burns
38. Late pulmonary sequela following burns: Presence of hyperprocalcitoninemia using a 1-57 amino acid N-terminal flanking peptide assay
39. Pneumonitis-associated hyperprocalcitoninemia
40. Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: Comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia
41. Outcome prediction by traditional and new markers of inflammation in patients with sepsis
42. Procalcitonin as a marker of severity in septic shock
43. Procalcitonin in diagnosis of severe infections
44. Procalcitonin used as a marker of infection in the intensive care unit
45. Calcitonin precursors are reliable markers of sepsis in the medical intensive care unit
46. Relationship between procalcitonin plasma levels and severity of injury, organ failure, and mortality in injured patients
47. Procalcitonin as a specific marker of bacterial infection in adults
48. Procalcitonin as a marker for the early diagnosis of neonatal infection
49. Procalcitonin and C-reactive protein levels in neonatal infections
50. Increased serum procalcitonin in newborn infants without infection
51. Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates
52. Increased serum procalcitonin levels are not specific to sepsis in neonates
53. Lack of specificity of procalcitonin for sepsis diagnosis in premature infants
54. Usefulness of procalcitonin in neonates at risk for infection
55. Serum procalcitonin concentrations in term delivering mothers and their healthy offspring: A longitudinal study
56. Measurement of procalcitonin levels in children with bacterial or viral meningitis
57. Procalcitonin in the early phase after renal transplantation - Will it add to diagnostic accuracy?
58. Procalcitonin: A new marker for differential diagnosis of acute rejection and bacterial infection in heart transplantation
59. Procalcitonin: A new marker for diagnosis of acute rejection and bacterial infection in patients after heart and lung transplantation
60. Diagnostic relevance of procalcitonin, IL-6 and cellular immune status in the early phase after liver transplantation
61. Procalcitonin, a new diagnostic and prognostic marker for severe infections